Title: Uptake of Two 10B-compounds in Liver Metastases of Colorectal Adenocarcinoma for Extracorporeal Irradiation with Boron Neutron Capture Therapy (EORTC trial 11001)
Authors: WITTIG AndreaMALAGO MassimoCOLLETTE LaurenceHUISKAMP R.BÜHRMANN SandraNIEVAART VICTOR ALEXANDERKAISER Gernot M.JÖCKEL Karl-HeinzSCHMID Kurt WernerORTMANN UtaSAUERWEIN Wolfgang
Citation: INTERNATIONAL JOURNAL OF CANCER vol. 122 p. 1164-1171
Publisher: WILEY-LISS
Publication Year: 2008
JRC N°: JRC43110
ISSN: 0020-7136
URI: www.interscience.wiley.com
http://publications.jrc.ec.europa.eu/repository/handle/JRC43110
Type: Articles in Journals
Abstract: Disseminated metastases of colorectal cancer in liver are incurable. The trial EORTC 11001 investigates whether autotransplantation after extracorporeal irradiation of the liver by boron neutron capture therapy (BNCT) might become a curative treatment option because of selective uptake of the compounds sodium mercaptoundecahydro-closo-dodecaborate (BSH) or L-para-boronophenylalanine (BPA). BSH (50 mg/kg bw) or BPA (100 mg/kg bw) were infused into patients who subsequently underwent resection of hepatic metastases. Blood and tissue samples were analyzed for the 10B-concentration with prompt gamma ray spectroscopy (PGRS). Three patients received BSH and 3 received BPA. Adverse effects from the boron carriers did not occur. For BSH, the highest 10B-concentration was observed in liver (31.5 6 2.7 lg/g) followed by blood (24.8 6 4.7 lg/g) and tumor (23.2 6 2.1 lg/g) with a mean 10B-concentration ratio metastasis/liver of 0.72 6 0.07. For BPA, the highest 10B-concentration was measured in metastases (12.1 6 2.2 lg/g) followed by liver (8.5 6 0.5 lg/g) and blood (5.8 6 0.8 lg/g). As BPA is transported actively into cells, viable, metabolically active cells accumulate exclusively this compound. Consequently, a model is proposed to adjust the values measured by PGRS for the proportion of viable cells to express the relevant 10B-concentration in the tumor cells, revealing a 10Bconcentration ratio metastasis/liver of 6.8 6 1.7. In conclusion, BSH is not suitable as 10B-carrier in liver metastases as the 10Bconcentration in liver was higher compared to metastasis. BPA accumulates in hepatic metastases to an extent that allows for extracorporeal irradiation of the liver with BNCT.
JRC Institute:Institute for Energy and Transport

Files in This Item:
There are no files associated with this item.


Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.